Association of Statin Medications on Development of De Novo Hepatocellular Carcinoma in Patients With Liver Cirrhosis and Diabetes Mellitus Type 2

被引：0
|
作者：
Verduzco, Esteban [1 ]
Chung, Raymond [1 ]
Yeh, Heidi [1 ]
机构：
[1] Harvard, Boston, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1536
引用
收藏
页码：S1163 / S1164
页数：2
相关论文
共 50 条
  • [21] Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin
    Donadon, Valter
    Balbi, Massimiliano
    Casarin, Pietro
    Vario, Alessandro
    Alberti, Alfredo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (37) : 5695 - 5700
  • [22] Development of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the MELD era
    Brady, Carla W.
    Smith, Alastair D.
    Stechuchak, Karen M.
    Coffman, Cynthia J.
    Tuttle-Newhall, Janet E.
    Provenzale, Dawn
    Muir, Andrew J.
    GASTROENTEROLOGY, 2006, 130 (04) : A754 - A754
  • [23] Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease
    Mantovani, Alessandro
    Targher, Giovanni
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (13)
  • [24] Medications for Weight Loss in Patients with Type 2 Diabetes Mellitus
    Kachowski, Larisa
    Over, Darrell R.
    Qiu, Kefeng
    AMERICAN FAMILY PHYSICIAN, 2012, 85 (06) : 633 - 635
  • [25] Effect of antiobesity medications in patients with type 2 diabetes mellitus
    Choussein, Souzana
    Makri, Angeliki A.
    Frangos, Constantinos C.
    Petridou, Eleni Th.
    Daskalopoulou, Stella S.
    DIABETES OBESITY & METABOLISM, 2009, 11 (07): : 641 - 664
  • [26] The Association of Metformin, Other Antidiabetic Medications, and Statins with the Prognosis of Hepatocellular Carcinoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study
    Tuunanen, Iida
    Hautakoski, Ari
    Huhtamaki, Heikki
    Arffman, Martti
    Sund, Reijo
    Puistola, Ulla
    Karihtala, Peeter
    Jukkola, Arja
    Urpilainen, Elina
    BIOMEDICINES, 2024, 12 (08)
  • [27] Influence of type 2 diabetes mellitus on tumour characteristics and outcomes in patients with hepatocellular carcinoma
    Lamprinou, A.
    Perakakis, N.
    Vach, W.
    Hennecke, N.
    Thimme, R.
    Blum, H. E.
    Laubner, K.
    Paeth, G.
    Seufert, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (03)
  • [28] Predictive score for the development of hepatocellular carcinoma in patients with liver cirrhosis.
    Rodriguez, M
    Velazquez, RF
    Navascues, CA
    Linares, A
    Perez, R
    Sotorrio, NG
    Martinez, I
    Espiga, MG
    Rodrigo, L
    HEPATOLOGY, 2001, 34 (04) : 179A - 179A
  • [29] Predictive score for the development of hepatocellular carcinoma in patients with liver cirrhosis.
    Abul, AR
    Omar, MM
    El Desouky, EM
    Solayman, AEM
    El Hendawy, SM
    HEPATOLOGY, 2002, 36 (04) : 392A - 392A
  • [30] The acarbose treatment of type 2 diabetes mellitus associated with liver cirrhosis
    Gentile, S
    Turco, S
    Persico, M
    Panariello, A
    Conte, S
    DeSeta, M
    Gesue, L
    Rossi, E
    Torella, R
    DIABETOLOGIA, 1997, 40 : 1204 - 1204
12345